Skip to main content
PMC home page
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2022 Jul 19;28:e937840-1. doi: 10.12659/MSM.937840

Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways

Liu Li 1, Lu Huizhi 2, Wang Binu 1, Deng Xinxin 1, Wu Longjun 1, Yang Liping 1, Zhang Yingying 1,✉
PMCID: PMC9308383  PMID: 35850997

Retraction Notice

An editorial decision has been made to retract this manuscript due to breach of publishing guidelines, following the identification of non-original and manipulated figures.

Reference

  1. Li Liu, Huizhi Lu, Binu Wang, Xinxin Deng, Longjun Wu, Liping Yang, Yingying Zhang. Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways. Med Sci Monit. 2018;24:7295–7302. doi: 10.12659/MSM.910702. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES